Natixis’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.1M | Buy |
74,117
+25,422
| +52% | +$12.8M | 0.13% | 110 |
|
|
2025
Q4 | $22.7M | Sell |
48,695
-2,858
| -6% | -$1.33M | 0.08% | 185 |
|
|
2025
Q3 | $22M | Sell |
51,553
-4,719
| -8% | -$1.83M | 0.1% | 177 |
|
|
2025
Q2 | $21.6M | Sell |
56,272
-2,514
| -4% | -$906K | 0.1% | 140 |
|
|
2025
Q1 | $20.3M | Sell |
58,786
-69,800
| -54% | -$22.4M | 0.11% | 148 |
|
|
2024
Q4 | $38.6M | Buy |
128,586
+43,628
| +51% | +$15.2M | 0.24% | 77 |
|
|
2024
Q3 | $34.5M | Buy |
84,958
+11,997
| +16% | +$4.39M | 0.19% | 88 |
|
|
2024
Q2 | $23.4M | Sell |
72,961
-30,103
| -29% | -$9.78M | 0.13% | 124 |
|
|
2024
Q1 | $34.4M | Sell |
103,064
-54,243
| -34% | -$16.6M | 0.18% | 100 |
|
|
2023
Q4 | $42.6M | Buy |
157,307
+106
| +0.1% | +$26.2K | 0.31% | 75 |
|
|
2023
Q3 | $38.7M | Buy |
157,201
+65,522
| +71% | +$17.9M | 0.3% | 72 |
|
|
2023
Q2 | $27.8M | Buy |
91,679
+26,001
| +40% | +$7.23M | 0.23% | 98 |
|
|
2023
Q1 | $17.3M | Sell |
65,678
-68,580
| -51% | -$17.4M | 0.16% | 133 |
|
|
2022
Q4 | $32.2M | Buy |
134,258
+48,901
| +57% | +$11M | 0.18% | 125 |
|
|
2022
Q3 | $15.9M | Buy |
85,357
+18,951
| +29% | +$3.78M | 0.07% | 201 |
|
|
2022
Q2 | $11.2M | Sell |
66,406
-32,026
| -33% | -$6.88M | 0.04% | 274 |
|
|
2022
Q1 | $24.7M | Buy |
98,432
+59,795
| +155% | +$15M | 0.09% | 223 |
|
|
2021
Q4 | $9.93M | Sell |
38,637
-7,660
| -17% | -$1.87M | 0.03% | 399 |
|
|
2021
Q3 | $11.2M | Buy |
46,297
+21,635
| +88% | +$5.29M | 0.04% | 344 |
|
|
2021
Q2 | $5.1M | Buy |
24,662
+16,069
| +187% | +$3.28M | 0.02% | 378 |
|
|
2021
Q1 | $1.62M | Sell |
8,593
-229,198
| -96% | -$40.4M | 0.01% | 743 |
|
|
2020
Q4 | $39.1M | Buy |
237,791
+42,709
| +22% | +$6.24M | 0.14% | 150 |
|
|
2020
Q3 | $24.3M | Sell |
195,082
-51,587
| -21% | -$6.39M | 0.18% | 124 |
|
|
2020
Q2 | $23.9M | Buy |
246,669
+89,785
| +57% | +$9.33M | 0.19% | 105 |
|
|
2020
Q1 | $14.1M | Buy |
+156,884
| New | +$20.3M | 0.11% | 170 |
|
|
2019
Q4 | – | Sell |
-267,908
| Closed | -$32.3M | – | 883 |
|
|
2019
Q3 | $32.3M | Buy |
267,908
+225,167
| +527% | +$29.1M | 0.21% | 109 |
|
|
2019
Q2 | $5.78M | Sell |
42,741
-454,467
| -91% | -$57.5M | 0.04% | 301 |
|
|
2019
Q1 | $64M | Buy |
497,208
+296,168
| +147% | +$39.8M | 0.4% | 51 |
|
|
2018
Q4 | $25M | Buy |
201,040
+50,767
| +34% | +$6.81M | 0.21% | 124 |
|
|
2018
Q3 | $20.9M | Sell |
150,273
-107,832
| -42% | -$13.4M | 0.12% | 176 |
|
|
2018
Q2 | $26.5M | Buy |
258,105
+48,212
| +23% | +$4.88M | 0.14% | 156 |
|
|
2018
Q1 | $20.4M | Buy |
+209,893
| New | +$20.4M | 0.13% | 175 |
|
|
2017
Q4 | – | Sell |
-5,954
| Closed | -$474K | – | 973 |
|
|
2017
Q3 | $474K | Sell |
5,954
-104,053
| -95% | -$8.37M | ﹤0.01% | 707 |
|
|
2017
Q2 | $9.59M | Buy |
+110,007
| New | +$9.31M | 0.11% | 180 |
|
|
2017
Q1 | – | Sell |
-260,754
| Closed | -$19.3M | – | 971 |
|
|
2016
Q4 | $19.3M | Buy |
+260,754
| New | +$19.5M | 0.2% | 128 |
|
|
2016
Q3 | – | Sell |
-119,406
| Closed | -$9.2M | – | 545 |
|
|
2016
Q2 | $9.2M | Buy |
+119,406
| New | +$9.43M | 0.17% | 127 |
|
|
2015
Q3 | – | Sell |
-4,371
| Closed | -$397K | – | 342 |
|
|
2015
Q2 | $397K | Sell |
4,371
-8,414
| -66% | -$674K | 0.01% | 276 |
|
|
2015
Q1 | $962K | Buy |
+12,785
| New | +$918K | 0.01% | 237 |
|
Other funds holding HCA
VCM
VPM
Natixis's HCA Position: Q1 2026 in Review
Natixis increased its HCA Healthcare (HCA) stake by 52% in Q1 2026, buying an estimated $12.8M and bringing the position to 74,117 shares worth $35.1M. The position accounts for 0.13% of the portfolio, ranked #110.
Natixis first reported a position in HCA in Q1 2015 and has held it in 38 quarters since. The position peaked at $64M in Q1 2019. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Natixis held 74,117 shares of HCA Healthcare worth $35.1M as of Q1 2026.
- Natixis bought 25,422 HCA Healthcare shares in Q1 2026, an estimated $12.8M.
- HCA Healthcare made up 0.13% of Natixis's portfolio in Q1 2026, its #110 holding.
- Natixis first reported a position in HCA Healthcare in Q1 2015 and has held it in 38 quarters since.
- Natixis's HCA Healthcare position peaked at $64M in Q1 2019.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.